You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amikacin Liposome Inhalation Suspension (ALIS)

Showing 1 - 25 of 2,575
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial (Liposomal Amikacin for Inhalation)

Completed
  • Healthy Volunteers
  • Liposomal Amikacin for Inhalation
  • (no location specified)
Aug 11, 2023

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +172 more
Jan 23, 2023

NTM Lung Infection Due to MAC Trial (LAI 590 mg, Multi-drug regimen)

Completed
Has Results
  • NTM Lung Infection Due to MAC
  • LAI 590 mg
  • Multi-drug regimen
  • (no location specified)
Jan 21, 2020

Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

Completed
Has Results
  • Mycobacterium Infections, Nontuberculous
  • LAI (Liposomal Amikacin for Inhalation) 590 mg
  • (no location specified)
Apr 22, 2020

Mycobacterium Infections, Nontuberculous Trial in Canada, United States (Liposomal amikacin for inhalation (LAI), )

Completed
Has Results
  • Mycobacterium Infections, Nontuberculous
  • Liposomal amikacin for inhalation (LAI)
  • placebo
  • Birmingham, Alabama
  • +18 more
Aug 6, 2019

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Active, not recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +110 more
Jan 23, 2023

COVID-19 Trial in Taipei (TLC19, TLC19 Vehicle)

Completed
  • COVID-19
  • Taipei, Taiwan
    Mackay Memorial Hospital Tamsui Branch
Nov 24, 2021

Cystic Fibrosis Trial in Worldwide (Arikayce™)

Completed
Has Results
  • Cystic Fibrosis
  • Leuven, Belgium
  • +10 more
Jul 20, 2020

Cystic Fibrosis Trial in Worldwide (ARIKACE™, Placebo)

Completed
Has Results
  • Cystic Fibrosis
  • Leuven, Belgium
  • +10 more
Jul 20, 2020

Pseudomonas Aeruginosa Infection Trial in Worldwide (Liposomal amikacin for inhalation (Arikayce™) using the PARI

Completed
Has Results
  • Pseudomonas Aeruginosa Infection
  • Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.
  • Tobramycin inhalation solution using a PARI LC® Plus nebulizer.
  • Vienna, Austria
  • +61 more
May 28, 2020

Cystic Fibrosis Trial in Worldwide (Liposomal amikacin for inhalation)

Completed
Has Results
  • Cystic Fibrosis
  • Liposomal amikacin for inhalation
  • Vienna, Austria
  • +49 more
Jun 10, 2020

Pain, Postoperative, Opioid Use, Perioperative Complication Trial (bupivacaine liposome injectable suspension, Bupivacaine

Not yet recruiting
  • Pain, Postoperative
  • +3 more
  • bupivacaine liposome injectable suspension
  • Bupivacaine Hydrochloride
  • (no location specified)
Oct 4, 2023

COPD Trial (HRS-9821)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • (no location specified)
Nov 14, 2022

COPD Trial in China (TQC3721 suspension for inhalation, TQC3721 matching for inhalation, Salbutamol sulfate inhalation aerosol)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • TQC3721 suspension for inhalation
  • +2 more
  • Guangzhou, Guangdong, China
  • +10 more
Aug 4, 2023

Snoring, Mouth Breathing Trial in Changsha (Nebulized Budesonide, Intranasal Budesonide Spray)

Not yet recruiting
  • Snoring
  • Mouth Breathing
  • Nebulized Budesonide
  • Intranasal Budesonide Spray
  • Changsha, Hunan, China
    Department of Otolaryngology, Second Xiangya Hospital, Central S
Apr 16, 2022

COPD (COPD) Trial in China (TQC3721 suspension for inhalation, TQC3721 suspension for inhalation)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • TQC3721 suspension for inhalation
  • TQC3721 suspension placebo for inhalation
  • Chongqing, Chongqing, China
  • +10 more
Jun 1, 2022

Cardiac Conditions Trial in Miami (Bupivacaine liposome)

Recruiting
  • Cardiac Conditions
  • Bupivacaine liposome
  • Miami, Florida
    Nickalus Children's Hospital f/k/a Miami Children's Hospital
Apr 4, 2022

Asthma Trial in Erpent (AQ001S 0.125 mg/ml, Budesonide 0.125 mg/ml inhalation suspension)

Recruiting
  • Asthma
  • AQ001S 0.125 mg/ml
  • Budesonide 0.125 mg/ml inhalation suspension
  • Erpent, Namur, Belgium
    Pneumocare SPRL
Nov 2, 2022

Probability of Optimal Target Attainment of Amikacin in Febrile

Recruiting
  • Febrile Neutropenia (FN)
  • Data collection: Amikacin concentration
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Jan 18, 2023

Pharmacokinetics Trial in Sofia (Budesonide Inhalant Product)

Completed
  • Pharmacokinetics
  • Budesonide Inhalant Product
  • Sofia, Bulgaria
    MC Comac Medical Ltd.
Feb 21, 2022

Ototoxicity, Drug-Induced Trial in United States (ORC-13661, Placebo)

Not yet recruiting
  • Ototoxicity, Drug-Induced
  • Denver, Colorado
  • +4 more
Feb 7, 2023

COPD Trial in Chengdu (TQC3721 suspension for inhalation, TQC3721 suspension for inhalation)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • TQC3721 suspension for inhalation
  • TQC3721 suspension placebo for inhalation
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 22, 2021

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)

Active, not recruiting
  • Small Cell Lung Cancer
  • Denver, Colorado
  • +117 more
Nov 22, 2022

Lung Cancer Trial in Shanghai (Bupivacaine Liposome SAPB, Traditional TPVB)

Recruiting
  • Lung Cancer
  • Bupivacaine Liposome SAPB
  • Traditional TPVB
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 15, 2023